• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾上腺皮质癌:医院容量对患者结局的影响。

Adrenocortical carcinoma: effect of hospital volume on patient outcome.

机构信息

Division of General and Endocrine Surgery, Università Cattolica del Sacro Cuore, Rome, Italy.

出版信息

Langenbecks Arch Surg. 2012 Feb;397(2):201-7. doi: 10.1007/s00423-011-0866-8. Epub 2011 Nov 9.

DOI:10.1007/s00423-011-0866-8
PMID:22069043
Abstract

PURPOSE

Optimal management of adrenocortical carcinoma (ACC) involves a detailed diagnostic workup, radical surgery, and appropriate adjuvant therapy. However, due to the rarity of this disease, adequate expertise is necessary to ensure optimal patient care. We evaluated if the experience of a treating center influences the outcome of ACC.

METHODS

Two hundred sixty-three patients who underwent adrenalectomy for ACC were included in a multi-institutional surgical survey and divided into 2 groups: "high-volume center" (HVC) (≥10 adrenalectomies for ACC) and "low-volume center" (LVC) (<10 adrenalectomies for ACC). A comparative analysis was performed.

RESULTS

One hundred seventy-two patients underwent adrenalectomy at HVC and 91 at LVC. The two groups were homogeneous for age, sex, clinical presentation, and stage. The mean lesions size of ACC was higher in HVC than in LVC (104.1 ± 54.6 vs 82.8 ± 41.3 mm; P < 0.001). A significantly higher rate of lymph node dissection (P < 0.01) and of multiorgan resection (P < 0.01) was accomplished in HVC. The number of patients who underwent adjuvant therapy was significantly higher in HVC (P < 0.001). Local recurrence rate was lower in patients treated at HVC (6% vs 18.5%; P = NS). Mean time to recurrence was significantly longer in HVC than in LVC (25.2 ± 28.1 vs 10.1 ± 7.5; P < 0.01).

CONCLUSION

The expertise of dedicated centers had a positive impact on the outcome of patients with ACC, resulting in a lower recurrence rate and improved mean time to recurrence. The improved patient outcome could be related not only to the appropriateness of the surgical procedure, but also to a more adequate multidisciplinary approach.

摘要

目的

肾上腺皮质癌(ACC)的最佳治疗需要详细的诊断检查、根治性手术和适当的辅助治疗。然而,由于这种疾病罕见,需要有足够的专业知识才能确保为患者提供最佳治疗。我们评估了治疗中心的经验是否会影响 ACC 的治疗效果。

方法

对 263 名接受肾上腺切除术治疗 ACC 的患者进行了多机构手术调查,并将其分为 2 组:“高容量中心”(HVC)(≥10 例 ACC 肾上腺切除术)和“低容量中心”(LVC)(<10 例 ACC 肾上腺切除术)。对这两组进行了对比分析。

结果

172 名患者在 HVC 进行了肾上腺切除术,91 名患者在 LVC 进行了肾上腺切除术。两组患者的年龄、性别、临床表现和分期均相似。HVC 中 ACC 的平均肿瘤大小大于 LVC(104.1 ± 54.6 与 82.8 ± 41.3 mm;P < 0.001)。HVC 中完成淋巴结清扫术(P < 0.01)和多器官切除术(P < 0.01)的比例明显更高。HVC 中接受辅助治疗的患者数量明显更多(P < 0.001)。HVC 中局部复发率较低(6%比 18.5%;P = NS)。HVC 中复发的平均时间明显长于 LVC(25.2 ± 28.1 与 10.1 ± 7.5;P < 0.01)。

结论

专门中心的专业知识对 ACC 患者的治疗效果产生了积极影响,降低了复发率并提高了复发的平均时间。患者预后的改善不仅与手术的适当性有关,还与更充分的多学科治疗方法有关。

相似文献

1
Adrenocortical carcinoma: effect of hospital volume on patient outcome.肾上腺皮质癌:医院容量对患者结局的影响。
Langenbecks Arch Surg. 2012 Feb;397(2):201-7. doi: 10.1007/s00423-011-0866-8. Epub 2011 Nov 9.
2
Surgery for recurrent adrenocortical carcinoma: A multicenter retrospective study.复发性肾上腺皮质癌的手术治疗:一项多中心回顾性研究。
Surgery. 2017 Jan;161(1):249-256. doi: 10.1016/j.surg.2016.08.058. Epub 2016 Nov 14.
3
Adrenocortical carcinoma surgery-surgical extent and approach.肾上腺皮质癌手术——手术范围及入路
Langenbecks Arch Surg. 2016 Nov;401(7):991-997. doi: 10.1007/s00423-016-1462-8. Epub 2016 Jul 13.
4
Proposal for modification of the ENSAT staging system for adrenocortical carcinoma using tumor grade.建议使用肿瘤分级修改肾上腺皮质癌的 ENSAT 分期系统。
Langenbecks Arch Surg. 2010 Sep;395(7):955-61. doi: 10.1007/s00423-010-0698-y. Epub 2010 Aug 9.
5
Long-term survival after adrenalectomy for stage I/II adrenocortical carcinoma (ACC): a retrospective comparative cohort study of laparoscopic versus open approach.I/II期肾上腺皮质癌(ACC)肾上腺切除术后的长期生存:腹腔镜与开放手术入路的回顾性比较队列研究
Ann Surg Oncol. 2014 Jan;21(1):284-91. doi: 10.1245/s10434-013-3164-6. Epub 2013 Sep 18.
6
Surgical management and clinical prognosis of adrenocortical carcinoma.肾上腺皮质癌的外科治疗与临床预后
Urol Int. 2012;88(4):400-4. doi: 10.1159/000336134. Epub 2012 Apr 5.
7
Borderline resectable adrenal cortical carcinoma: a potential role for preoperative chemotherapy.边缘可切除性肾上腺皮质癌:术前化疗的潜在作用
World J Surg. 2014 Jun;38(6):1318-27. doi: 10.1007/s00268-014-2484-4.
8
Survival and prognostic factors for adrenocortical carcinoma: a single institution experience.肾上腺皮质癌的生存及预后因素:单中心经验
BMC Urol. 2015 May 27;15:43. doi: 10.1186/s12894-015-0038-1.
9
Operative intervention for recurrent adrenocortical cancer.手术干预复发性肾上腺皮质癌。
Surgery. 2013 Dec;154(6):1292-9; discussion 1299. doi: 10.1016/j.surg.2013.06.033.
10
Impact of lymphadenectomy on the oncologic outcome of patients with adrenocortical carcinoma.淋巴结清扫术对肾上腺皮质癌患者肿瘤学结局的影响。
Ann Surg. 2012 Feb;255(2):363-9. doi: 10.1097/SLA.0b013e3182367ac3.

引用本文的文献

1
Impact of en bloc extended R0 resections on oncological outcome of locally advanced adrenocortical carcinoma.整块扩大R0切除对局部晚期肾上腺皮质癌肿瘤学结局的影响。
Updates Surg. 2025 May 3. doi: 10.1007/s13304-025-02215-z.
2
Current state-of-the-art of adrenal surgery in Italy: the cancer risk in surgical adrenal lesions (CRISAL) survey.意大利肾上腺手术的当前技术水平:手术肾上腺病变癌症风险(CRISAL)调查
Updates Surg. 2025 Mar 17. doi: 10.1007/s13304-025-02139-8.
3
Centralization of adrenal surgeries and improved surgeon volume outcomes.

本文引用的文献

1
Deficits in the management of patients with adrenocortical carcinoma in Germany.德国肾上腺皮质癌患者管理中的不足。
Dtsch Arztebl Int. 2010 Dec;107(50):885-91. doi: 10.3238/arztebl.2010.0885. Epub 2010 Dec 17.
2
Improved survival in patients with stage II adrenocortical carcinoma followed up prospectively by specialized centers.经专门中心前瞻性随访的 II 期肾上腺皮质癌患者的生存率提高。
J Clin Endocrinol Metab. 2010 Nov;95(11):4925-32. doi: 10.1210/jc.2010-0803. Epub 2010 Jul 28.
3
Results of adrenal surgery. Data of a Spanish National Survey.
肾上腺手术的集中化与外科医生手术量增加带来的改善结果。
Gland Surg. 2024 Sep 30;13(9):1662-1664. doi: 10.21037/gs-24-201. Epub 2024 Sep 19.
4
System analysis identifies UBE2C as a novel oncogene target for adrenocortical carcinoma.系统分析鉴定 UBE2C 为肾上腺皮质癌的一个新的癌基因靶标。
PLoS One. 2023 Aug 3;18(8):e0289418. doi: 10.1371/journal.pone.0289418. eCollection 2023.
5
Impact of Current Technology in Laparoscopic Adrenalectomy: 20 Years of Experience in the Treatment of 254 Consecutive Clinical Cases.当前技术在腹腔镜肾上腺切除术中的影响:254例连续临床病例20年治疗经验
J Clin Med. 2023 Jun 29;12(13):4384. doi: 10.3390/jcm12134384.
6
Construction and validation of a prognostic model for predicting overall survival of primary adrenal malignant tumor patients: A population-based study with 1,080 patients.预测原发性肾上腺恶性肿瘤患者总生存期的预后模型的构建与验证:一项基于1080例患者的人群研究。
Front Surg. 2022 Oct 24;9:1025213. doi: 10.3389/fsurg.2022.1025213. eCollection 2022.
7
Prognostic factors and mitotane treatment of adrenocortical cancer. Two decades of experience from an institutional case series.肾上腺皮质癌的预后因素和米托坦治疗。来自机构病例系列的 20 年经验。
Front Endocrinol (Lausanne). 2022 Sep 29;13:952418. doi: 10.3389/fendo.2022.952418. eCollection 2022.
8
Robotic Adrenalectomy: A 10-Year Clinical Experience at a Tertiary Medical Center.机器人辅助肾上腺切除术:三级医疗中心的 10 年临床经验。
JSLS. 2022 Jan-Mar;26(1). doi: 10.4293/JSLS.2021.00083.
9
Volume-outcome relationships in laryngeal trauma processes of care: a retrospective cohort study.喉外伤治疗过程中的量效关系:回顾性队列研究。
Eur J Trauma Emerg Surg. 2022 Oct;48(5):4131-4141. doi: 10.1007/s00068-022-01950-x. Epub 2022 Mar 23.
10
Temporal Trends in Outcomes in Patients With Adrenocortical Carcinoma: A Multidisciplinary Referral-center Experience.肾上腺皮质癌患者结局的时间趋势:多学科转诊中心的经验。
J Clin Endocrinol Metab. 2022 Apr 19;107(5):1239-1246. doi: 10.1210/clinem/dgac046.
肾上腺手术结果。一项西班牙全国性调查的数据。
Langenbecks Arch Surg. 2010 Sep;395(7):837-43. doi: 10.1007/s00423-010-0697-z. Epub 2010 Jul 25.
4
Laparoscopic versus open adrenalectomy for adrenocortical carcinoma: surgical and oncologic outcome in 152 patients.腹腔镜与开放肾上腺切除术治疗肾上腺皮质癌:152 例患者的手术和肿瘤学结果。
Eur Urol. 2010 Oct;58(4):609-15. doi: 10.1016/j.eururo.2010.06.024. Epub 2010 Jun 22.
5
Laparoscopic resection is inappropriate in patients with known or suspected adrenocortical carcinoma.腹腔镜切除术不适用于已知或疑似肾上腺皮质癌的患者。
World J Surg. 2010 Jun;34(6):1380-5. doi: 10.1007/s00268-010-0532-2.
6
Retrospective evaluation of the outcome of open versus laparoscopic adrenalectomy for stage I and II adrenocortical cancer.回顾性评估 I 期和 II 期肾上腺皮质癌行开放与腹腔镜肾上腺切除术的疗效。
Eur Urol. 2010 May;57(5):873-8. doi: 10.1016/j.eururo.2010.01.036. Epub 2010 Jan 26.
7
Outcomes from 3144 adrenalectomies in the United States: which matters more, surgeon volume or specialty?美国3144例肾上腺切除术的结果:外科医生手术量还是专业更重要?
Arch Surg. 2009 Nov;144(11):1060-7. doi: 10.1001/archsurg.2009.191.
8
Recurrence of adrenal cortical carcinoma following resection: surgery alone can achieve results equal to surgery plus mitotane.肾上腺皮质癌切除术后复发:单纯手术与手术加米托坦治疗效果相当。
Ann Surg Oncol. 2010 Jan;17(1):263-70. doi: 10.1245/s10434-009-0716-x. Epub 2009 Oct 23.
9
Clinical management of adrenocortical carcinoma.肾上腺皮质癌的临床管理
Best Pract Res Clin Endocrinol Metab. 2009 Apr;23(2):273-89. doi: 10.1016/j.beem.2008.10.008.
10
Adrenocortical carcinoma in the United States: treatment utilization and prognostic factors.美国肾上腺皮质癌:治疗利用情况及预后因素。
Cancer. 2008 Dec 1;113(11):3130-6. doi: 10.1002/cncr.23886.